Al-Omar Lana T, Anderson Sarah L, Cizmic Amber D, Vlasimsky Tara B
Inpatient Clinical Staff Pharmacist, Denver Health Medical Center, CO.
Ambulatory Care Clinical Pharmacy Specialist, Denver Health Medical Center, and Associate Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora.
Am Health Drug Benefits. 2019 Feb;12(1):14-20.
Little data exist regarding how pharmacist-led collaborative drug therapy management protocols are implemented in health systems. Barriers to collaborative drug therapy management protocol implementation exist, but they can be overcome by effective protocol education and communication, allowing pharmacists to manage more patients with chronic disease states, thereby enhancing quality health outcomes for patients and reducing health resource utilization.
To determine the preferred method of provider education regarding the implementation of a pharmacist-led type 2 diabetes collaborative drug therapy management protocol, and to assess pharmacist and provider satisfaction with the protocol implementation.
This single-center, prospective cohort study included pharmacists practicing within a pharmacist-led type 2 diabetes collaborative drug therapy management protocol, as well as providers practicing at 4 primary care clinics within a health system. All providers received an e-mail regarding education about the protocol. In addition, providers at 2 of the clinics received education about the protocol at a provider meeting, and providers at the other 2 clinics received a personalized provider report card. The personalized provider report card identified patients within the provider's panel who met criteria for referral to a pharmacist under the new protocol. The referred patients were tracked for 2 months, and provider and pharmacist satisfaction with the protocol were assessed.
A total of 54 patients were referred for pharmacist management per the protocol. The majority (89%) of patients were referred by providers who received a personalized provider report card. Nearly all (96%) of the providers were satisfied with the protocol-driven services, and most (67%) pharmacists were satisfied with their role in managing patients with type 2 diabetes under the collaborative drug therapy management protocol.
The majority of patients with type 2 diabetes who were referred for pharmacist management per the protocol were referred by providers who received personalized provider report cards. Provider and pharmacist satisfaction with the new pharmacist-led protocol was high.
关于药剂师主导的协作药物治疗管理方案在卫生系统中如何实施的数据很少。协作药物治疗管理方案的实施存在障碍,但可以通过有效的方案教育和沟通来克服,这使得药剂师能够管理更多患有慢性病的患者,从而提高患者的健康结局质量并减少卫生资源的利用。
确定关于实施药剂师主导的2型糖尿病协作药物治疗管理方案的提供者教育的首选方法,并评估药剂师和提供者对该方案实施的满意度。
这项单中心前瞻性队列研究纳入了在药剂师主导的2型糖尿病协作药物治疗管理方案下执业的药剂师,以及在一个卫生系统内4家初级保健诊所执业的提供者。所有提供者都收到了一封关于该方案教育的电子邮件。此外,其中2家诊所的提供者在一次提供者会议上接受了关于该方案的教育,另外2家诊所的提供者收到了个性化的提供者报告卡。个性化的提供者报告卡确定了提供者小组中符合新方案下转介给药剂师标准的患者。对转介的患者进行了2个月的跟踪,并评估了提供者和药剂师对该方案的满意度。
根据该方案,共有54名患者被转介给药剂师管理。大多数(89%)患者是由收到个性化提供者报告卡的提供者转介的。几乎所有(96%)的提供者对方案驱动的服务感到满意,大多数(67%)药剂师对他们在协作药物治疗管理方案下管理2型糖尿病患者的角色感到满意。
根据该方案被转介给药剂师管理的大多数2型糖尿病患者是由收到个性化提供者报告卡的提供者转介的。提供者和药剂师对新的药剂师主导方案的满意度很高。